I read the article published by Ciftci et al. 1 with great interest. They investigated the mean platelet volume (MPV) values in patients with vasculogenic erectile dysfunction (ED) and nonvasculogenic ED and compared them with controls. They found that MPV and platelet count values were significantly higher in patients with vasculogenic ED than in patients with nonvasculogenic ED and controls. The MPV and platelet count values were not significantly different between patients with non-vasculogenic ED and controls. I congratulate the authors for their succesfull study. However, I want to make minor criticism about this study from methodological aspect.
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Basically, the method used for MPV assessment is correct. However, it has to be kept in mind that there are significant associations of MPV with some cardiovascular conditions like smoking, obesity, hyperlipidemia, hypertension, coronary artery disease, metabolic syndrome, statin and antihypertensive use and atrial fibrillation. 2 They excluded diabetes mellitus, smoking, hypertension and coronary artery disease. However, they did not mention about the body mass index, blood lipid levels, and presence of metabolic syndrome and atrial fibrillation. It has been shown that obesity, hyperlipidemia, metabolic syndrome and atrial fibrillation increase MPV values. 2 Absolutely, these factors should be considered in MPV assessment. It would have been useful if the authors had provided this information.
Increased MPV values were observed in patients with diabetes mellitus, hypertension, hypercholesterolemia, smoking, and obesity suggesting a common mechanism by which these factors may increase the risk of cardiovascular disease and vasculogenic ED. As a result, cardiovascular risk factors causing endothelial dysfunction and ED can also cause increased MPV values. Recently, it has been demonstrated that subclinical endothelial dysfunction and low-grade inflammation may be the underlying pathogenesis of ED with no well-known etiology. 3 Platelet activation has a major role in the pathophysiology of diseases prone to thrombosis and inflammation. In association with this MPV might be a link between thrombosis and inflammation. 4 It might be speculated that inflammation existing in patients with ED might cause increased platelet reactivity as measured by MPV in these patients.
MPV is universally available with routine blood counts by automated hemograms and a simple and easy method of assessing platelet function. In comparison to smaller ones, larger platelets have more granules, that aggregate more rapidly with collagen, have higher thromboxane A2 level and express more glycoprotein Ib and IIb/IIIa receptors. [2] [3] [4] [5] I believe that MPV can be affected by many inflammatory and cardiovascular risk factors. Because of that all confounding factors must be considered.
